Table 3 Univariate COX analysis of risk factors correlated with 365-day all-cause mortality
Variables | HR (95%CI) | P-value |
|---|---|---|
ACAG | 1.07 (1.06 ∼ 1.08) | < 0.01 |
Age (years) | 1.04 (1.03 ∼ 1.04) | < 0.01 |
Sex, male, n (%) | 0.84 (0.74 ∼ 0.94) | < 0.01 |
Myocardial infarction, n (%) | 1.26 (1.11 ∼ 1.43) | < 0.01 |
Congestive heart failure, n (%) | 1.28 (1.14 ∼ 1.43) | < 0.01 |
Diabetes, n (%) | 1.13 (1.01 ∼ 1.28) | 0.05 |
Obesity, n (%) | 0.69 (0.57 ∼ 0.85) | < 0.01 |
Peripheral vascular disease, n (%) | 1.24 (1.06 ∼ 1.44) | < 0.01 |
Cerebrovascular disease, n (%) | 1.33 (1.17 ∼ 1.51) | < 0.01 |
Paraplegia, n (%) | 1.30 (1.09 ∼ 1.56) | < 0.01 |
Renal Disease, n (%) | 1.45 (1.28 ∼ 1.64) | < 0.01 |
Liver Disease, n (%) | 1.58 (1.28 ∼ 1.96) | < 0.01 |
Hematocrit, % | 0.99 (0.98 ∼ 0.99) | 0.02 |
Hemoglobin, g/dL | 0.94 (0.91 ∼ 0.96) | < 0.01 |
WBC, K/uL | 1.01 (1,0.01 ∼ 1.02) | < 0.01 |
RDW, % | 1.12 (1.10 ∼ 1.15) | < 0.01 |
Albumin, g/dL | 0.68 (0.62 ∼ 0.75) | < 0.01 |
AG, mmol/L | 1.06 (1.05 ∼ 1.07) | < 0.01 |
BUN, mg/dL | 1.01 (1.01 ∼ 1.01) | < 0.01 |
Creatinine, mg/dL | 1.11 (1.08 ∼ 1.15) | < 0.01 |
Glucose, g/dL | 1.01 (1.01 ∼ 1.01) | < 0.01 |
Sodium, mEq/L | 1.03 (1.01 ∼ 1.04) | < 0.01 |
Potassium, mEq/L | 1.24 (1.17 ∼ 1.30) | < 0.01 |
INR | 1.07 (1.05 ∼ 1.10) | < 0.01 |
prothrombin time, s | 1.01 (1.01 ∼ 1.01) | < 0.01 |
Partial thromboplastin time, s | 1.01 (1.01 ∼ 1.01) | 0.02 |
Systolic blood pressure, mmHg | 0.99 (0.99 ∼ 0.99) | < 0.01 |
Diastolic blood pressure, mmHg | 0.98 (0.98 ∼ 0.99) | < 0.01 |
Mean blood pressure, mmHg | 0.98 (0.98 ∼ 0.99) | < 0.01 |
SOFA | 1.11 (1.09 ∼ 1.12) | < 0.01 |
OASIS | 1.06 (1.05 ∼ 1.06) | < 0.01 |
SAPS II | 1.04 (1.04 ∼ 1.04) | < 0.01 |
Statin | 0.80 (0.71 ∼ 0.90) | < 0.01 |
Beta-Blockers | 0.79 (0.70 ∼ 0.89) | < 0.01 |
ACEI/ARB | 0.73 (0.59 ∼ 0.90) | < 0.01 |
Heparin | 1.18 (1.02 ∼ 1.36) | 0.02 |
Warfarin | 0.68 (0.58 ∼ 0.80) | < 0.01 |